Statin and Atheroma Vulnerability Evaluation

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 312 participants.

Also called NCT00997880

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 312 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT00997880
Other papers using this trial's data
  • Effect of Statin Treatment on Modifying Plaque Composition: A Double-Blind, Randomized Study Journal of the American College of Cardiology, 2016-04-19 DOI, PubMed 27081016
  • Relationship Between Serum Inflammatory Marker Levels and the Dynamic Changes in Coronary Plaque Characteristics After Statin Therapy Circulation. Cardiovascular imaging, 2017-07 DOI, PubMed 28679524

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT00997880. Randomized; triple masking; primary purpose treatment. Start 2010-04 (registry gives no type); primary completion 2014-12 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Statin and Atheroma Vulnerability Evaluation
Acronym
STABLE
Intervention (Drug)
Rosuvastatin calcium 40mg
Intervention (Drug)
Rosuvastatin calcium10mg
Lead sponsor
Seung-Jung Park (class: other)
Collaborator
CardioVascular Research Foundation, Korea (class: other)

Record details

Record id
cardio:ct-nct00997880
Content hash
b4234cafaaa6861002182a346fe9e73630ae600fb652115d97cb9c5807d9f091